The University of Chicago Header Logo

Susan L. Cohn

Concepts (412)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neuroblastoma
101
2023
375
20.870
Why?
Infant
61
2023
3048
2.190
Why?
Antineoplastic Combined Chemotherapy Protocols
20
2022
2438
2.000
Why?
N-Myc Proto-Oncogene Protein
20
2023
36
1.940
Why?
Child, Preschool
52
2023
3612
1.850
Why?
Anti-HIV Agents
4
2021
149
1.810
Why?
Opsoclonus-Myoclonus Syndrome
3
2020
4
1.770
Why?
HIV Infections
10
2022
773
1.580
Why?
Child
58
2023
6928
1.530
Why?
3-Iodobenzylguanidine
8
2022
19
1.440
Why?
Neoplasm Recurrence, Local
11
2023
1313
1.320
Why?
Gene Amplification
10
2021
131
1.300
Why?
Induction Chemotherapy
5
2022
147
1.280
Why?
Prognosis
34
2023
3681
1.260
Why?
Disease-Free Survival
24
2023
1204
1.220
Why?
Oncogene Proteins
13
2015
59
1.150
Why?
Biomarkers, Tumor
7
2021
1464
1.100
Why?
Humans
117
2023
86648
1.050
Why?
Neoplasms, Second Primary
5
2023
252
1.010
Why?
Central Nervous System Neoplasms
2
2023
81
0.930
Why?
Antineoplastic Agents
13
2016
2360
0.920
Why?
Pelvic Neoplasms
3
2014
45
0.920
Why?
5-Methylcytosine
3
2022
112
0.890
Why?
Antibodies, Monoclonal
8
2021
1380
0.890
Why?
Neoplasm Staging
23
2023
1938
0.880
Why?
Cell-Free Nucleic Acids
2
2023
71
0.870
Why?
Immunotherapy
8
2021
631
0.850
Why?
Nuclear Proteins
13
2015
705
0.840
Why?
Gene Expression Regulation, Neoplastic
8
2022
1197
0.840
Why?
HIV-1
3
2021
164
0.820
Why?
Cell Proliferation
5
2019
1596
0.790
Why?
Response Evaluation Criteria in Solid Tumors
2
2020
56
0.780
Why?
Immunoglobulins, Intravenous
2
2020
66
0.780
Why?
Neoplasms, Muscle Tissue
1
2020
11
0.740
Why?
Pharmaceutical Preparations
1
2021
92
0.730
Why?
Hematopoietic Stem Cell Transplantation
4
2022
878
0.720
Why?
DNA Methylation
4
2022
630
0.720
Why?
Adolescent
34
2021
8981
0.710
Why?
Female
59
2022
44561
0.700
Why?
Stem Cell Transplantation
8
2019
183
0.690
Why?
Epigenomics
1
2019
100
0.670
Why?
Chromosome Aberrations
6
2020
387
0.660
Why?
Naphthyridines
1
2019
53
0.650
Why?
Decision Support Techniques
1
2019
160
0.620
Why?
Oligonucleotide Array Sequence Analysis
3
2016
691
0.610
Why?
Male
48
2021
40990
0.590
Why?
Cell Line, Tumor
12
2022
2427
0.590
Why?
Prednisone
1
2017
258
0.590
Why?
Neoadjuvant Therapy
1
2019
318
0.590
Why?
Serum Albumin, Bovine
1
2016
45
0.580
Why?
Palmitic Acid
1
2016
27
0.580
Why?
Osteonectin
1
2016
22
0.580
Why?
Risk Factors
19
2021
5416
0.570
Why?
Survival Rate
14
2021
1864
0.570
Why?
Combined Modality Therapy
9
2023
1686
0.560
Why?
Infant, Newborn
14
2021
2380
0.560
Why?
Medical Oncology
3
2021
359
0.550
Why?
Isotretinoin
3
2021
23
0.550
Why?
Lipid Metabolism
1
2016
197
0.530
Why?
Altruism
1
2015
35
0.520
Why?
Anti-Inflammatory Agents
1
2017
339
0.510
Why?
Interleukin-2
4
2022
250
0.500
Why?
Genetic Predisposition to Disease
5
2017
2272
0.500
Why?
Follow-Up Studies
12
2021
3639
0.490
Why?
Adrenal Gland Neoplasms
4
2017
80
0.480
Why?
Molecular Targeted Therapy
1
2016
266
0.470
Why?
Genomics
3
2021
720
0.460
Why?
Radiation Injuries
1
2014
156
0.450
Why?
Cohort Studies
13
2021
2763
0.440
Why?
Risk Assessment
11
2023
2261
0.440
Why?
Salvage Therapy
4
2021
233
0.440
Why?
Bone Marrow Neoplasms
3
2020
17
0.440
Why?
Hypoxia
2
2022
642
0.430
Why?
Radiotherapy
1
2014
328
0.430
Why?
Pediatrics
2
2021
344
0.430
Why?
L-Lactate Dehydrogenase
3
2020
68
0.410
Why?
Drug Resistance, Neoplasm
7
2021
592
0.410
Why?
Treatment Outcome
14
2022
7981
0.400
Why?
Microtubule-Associated Proteins
1
2012
182
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2357
0.400
Why?
Benzenesulfonates
1
2011
66
0.400
Why?
Young Adult
16
2021
5976
0.400
Why?
Limbic Encephalitis
1
2011
11
0.400
Why?
Algorithms
1
2019
1830
0.390
Why?
Age Factors
11
2021
1849
0.390
Why?
MAP Kinase Signaling System
1
2011
193
0.390
Why?
Prospective Studies
11
2023
4212
0.380
Why?
Kaplan-Meier Estimate
9
2016
861
0.380
Why?
Quinoxalines
1
2011
50
0.380
Why?
Pyridines
2
2012
310
0.380
Why?
Iodine Radioisotopes
4
2022
134
0.380
Why?
Neoplasm Metastasis
7
2019
1056
0.370
Why?
Parents
3
2023
272
0.360
Why?
Palliative Care
2
2023
257
0.350
Why?
Recurrence
5
2023
1139
0.350
Why?
Angiogenesis Inhibitors
1
2011
311
0.340
Why?
International Cooperation
3
2020
127
0.340
Why?
Biomedical Research
3
2021
376
0.330
Why?
Protein Kinase Inhibitors
2
2016
589
0.330
Why?
Health Status Disparities
1
2010
170
0.330
Why?
Drug Administration Schedule
2
2019
915
0.310
Why?
Proportional Hazards Models
7
2021
860
0.300
Why?
Survivors
3
2022
227
0.290
Why?
Adult
22
2021
25647
0.290
Why?
Ganglioneuroblastoma
2
2018
4
0.270
Why?
Gene Expression Profiling
3
2016
1387
0.270
Why?
United States
6
2021
6674
0.270
Why?
Risk
4
2019
674
0.260
Why?
Proto-Oncogene Proteins
2
2022
645
0.260
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2022
112
0.260
Why?
Chromosomes, Human, Pair 11
3
2020
106
0.240
Why?
Mixed Function Oxygenases
2
2022
68
0.240
Why?
Genome-Wide Association Study
3
2017
1621
0.240
Why?
Survival Analysis
7
2021
1540
0.240
Why?
Gangliosides
2
2016
10
0.240
Why?
Thoracic Neoplasms
2
2014
64
0.240
Why?
Radionuclide Imaging
3
2021
220
0.240
Why?
Transplantation, Autologous
2
2022
331
0.230
Why?
Receptor Protein-Tyrosine Kinases
2
2016
153
0.230
Why?
Gene Frequency
2
2017
677
0.230
Why?
Pregnancy Complications, Infectious
3
2009
105
0.230
Why?
Disease Progression
5
2014
1534
0.230
Why?
Lymph Nodes
2
2019
533
0.220
Why?
Radioimmunotherapy
1
2023
25
0.220
Why?
Peripheral Blood Stem Cell Transplantation
2
2013
67
0.220
Why?
Bone Neoplasms
2
2017
321
0.220
Why?
Watchful Waiting
2
2013
60
0.220
Why?
Time Factors
6
2019
5215
0.220
Why?
Ferritins
2
2020
29
0.220
Why?
Cell Hypoxia
3
2022
165
0.220
Why?
Brain Neoplasms
3
2014
763
0.210
Why?
Chromosomes, Human, Pair 1
2
2020
100
0.210
Why?
Hypoxia-Inducible Factor 1
1
2022
42
0.210
Why?
Central Nervous System
1
2023
151
0.210
Why?
Transcriptome
2
2016
580
0.200
Why?
Cancer Survivors
1
2022
85
0.200
Why?
Neoplasm, Residual
1
2022
162
0.200
Why?
Neoplasms
3
2021
2898
0.200
Why?
Retrospective Studies
8
2023
8475
0.190
Why?
Nomograms
1
2020
28
0.190
Why?
Research Subjects
1
2021
73
0.190
Why?
Genotype
2
2017
1853
0.190
Why?
Research Report
3
2021
44
0.190
Why?
Antineoplastic Agents, Immunological
2
2019
185
0.180
Why?
Rituximab
1
2020
116
0.180
Why?
Incidence
4
2022
1578
0.180
Why?
Cell Differentiation
4
2015
1471
0.180
Why?
Attitude to Death
1
2019
36
0.180
Why?
Mice
5
2019
11439
0.180
Why?
Myeloablative Agonists
2
2016
34
0.180
Why?
Mitotic Index
2
2020
20
0.170
Why?
Anti-Retroviral Agents
1
2019
30
0.170
Why?
Cell Movement
3
2022
762
0.170
Why?
Drug Interactions
1
2019
248
0.170
Why?
Cell Cycle
2
2011
503
0.170
Why?
Clinical Trials as Topic
5
2020
1169
0.170
Why?
Antiretroviral Therapy, Highly Active
4
2009
64
0.170
Why?
Ganglioneuroma
1
2018
9
0.170
Why?
Clinical Trials, Phase III as Topic
3
2017
172
0.170
Why?
Social Stigma
1
2019
52
0.170
Why?
Adrenal Cortex Hormones
1
2020
261
0.160
Why?
Heterografts
1
2019
98
0.160
Why?
Mitosis
2
2020
153
0.160
Why?
Databases, Factual
3
2017
816
0.160
Why?
Antineoplastic Agents, Alkylating
2
2016
138
0.160
Why?
Lymphoma
1
2019
262
0.160
Why?
Tumor Microenvironment
1
2021
418
0.160
Why?
Receptors, KIR
1
2017
10
0.160
Why?
B7-H1 Antigen
1
2019
250
0.150
Why?
Neoplasms, Complex and Mixed
1
2017
7
0.150
Why?
Ataxia
1
2017
37
0.150
Why?
Neurologic Examination
1
2017
118
0.150
Why?
Pheochromocytoma
1
2017
49
0.150
Why?
Nurse's Role
1
2017
12
0.150
Why?
Biomarkers
3
2020
1722
0.150
Why?
Age of Onset
2
2015
310
0.150
Why?
Clinical Decision-Making
1
2019
257
0.150
Why?
Patient Acceptance of Health Care
1
2019
238
0.140
Why?
Databases, Nucleic Acid
1
2016
41
0.140
Why?
Human Umbilical Vein Endothelial Cells
1
2016
63
0.140
Why?
Neoplasm Proteins
1
2020
532
0.140
Why?
Maintenance Chemotherapy
1
2017
76
0.140
Why?
Buthionine Sulfoximine
1
2016
7
0.140
Why?
Mutation
3
2016
3977
0.140
Why?
Recovery of Function
1
2017
271
0.140
Why?
Soft Tissue Neoplasms
1
2017
126
0.140
Why?
Tissue Fixation
1
2016
40
0.140
Why?
Paraffin Embedding
1
2016
78
0.140
Why?
Formaldehyde
1
2016
52
0.140
Why?
Melphalan
1
2016
98
0.140
Why?
Multivariate Analysis
3
2014
999
0.140
Why?
Medication Adherence
1
2017
129
0.140
Why?
Predictive Value of Tests
3
2015
1672
0.130
Why?
Thiamine
1
2015
8
0.130
Why?
Wernicke Encephalopathy
1
2015
6
0.130
Why?
Melanoma
1
2019
459
0.130
Why?
Genes, myc
1
2015
39
0.130
Why?
Autografts
4
2017
28
0.130
Why?
Diffusion of Innovation
1
2015
71
0.130
Why?
Lymphatic Metastasis
2
2014
486
0.130
Why?
Positron-Emission Tomography
1
2017
329
0.130
Why?
Apoptosis
2
2019
1689
0.130
Why?
Hydroxamic Acids
1
2015
49
0.130
Why?
Immunosuppressive Agents
1
2020
977
0.130
Why?
In Situ Hybridization, Fluorescence
2
2012
349
0.130
Why?
Genetic Association Studies
2
2016
294
0.130
Why?
Peripheral Nervous System Neoplasms
1
2014
19
0.130
Why?
Interdisciplinary Communication
1
2015
130
0.120
Why?
Radiation-Sensitizing Agents
1
2015
95
0.120
Why?
Antimetabolites, Antineoplastic
1
2016
236
0.120
Why?
Genetic Therapy
1
2016
343
0.120
Why?
Karyotyping
1
2014
250
0.120
Why?
DNA Copy Number Variations
2
2012
171
0.120
Why?
Cell Survival
1
2016
971
0.120
Why?
Cooperative Behavior
1
2015
176
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2019
931
0.120
Why?
Dacarbazine
2
2013
102
0.120
Why?
Choice Behavior
1
2015
160
0.120
Why?
Orbital Neoplasms
1
2013
17
0.120
Why?
Animals
5
2019
26704
0.120
Why?
Patient Selection
2
2015
686
0.120
Why?
SEER Program
1
2014
190
0.120
Why?
Tubulin Modulators
1
2013
24
0.120
Why?
Reproducibility of Results
2
2018
2704
0.120
Why?
Abdominal Neoplasms
1
2013
39
0.120
Why?
Immunomagnetic Separation
1
2013
8
0.120
Why?
Camptothecin
2
2013
189
0.120
Why?
Odds Ratio
2
2012
679
0.120
Why?
Pyrazoles
2
2012
153
0.120
Why?
Cell Nucleolus
1
2013
23
0.120
Why?
Image Interpretation, Computer-Assisted
1
2018
663
0.120
Why?
Retroperitoneal Neoplasms
1
2013
43
0.120
Why?
Pyrimidines
2
2018
370
0.110
Why?
Computational Biology
1
2016
528
0.110
Why?
Mice, Nude
2
2012
789
0.110
Why?
Renal Insufficiency
1
2013
114
0.110
Why?
Case-Control Studies
1
2017
1809
0.110
Why?
Cluster Analysis
1
2014
369
0.110
Why?
Xenograft Model Antitumor Assays
2
2012
458
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2013
120
0.110
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2012
57
0.110
Why?
Fenretinide
1
2011
2
0.100
Why?
Severity of Illness Index
1
2017
1804
0.100
Why?
Topoisomerase I Inhibitors
1
2011
33
0.100
Why?
Oncogene Proteins, Fusion
1
2012
128
0.100
Why?
Topotecan
1
2011
45
0.100
Why?
Drug Monitoring
3
2018
118
0.100
Why?
Sulfonamides
1
2013
300
0.100
Why?
Multidrug Resistance-Associated Proteins
1
2011
27
0.100
Why?
Niacinamide
1
2011
116
0.100
Why?
Loss of Heterozygosity
3
2018
85
0.100
Why?
Randomized Controlled Trials as Topic
1
2015
864
0.100
Why?
Phenylurea Compounds
1
2011
114
0.100
Why?
Neoplasm Transplantation
1
2011
392
0.100
Why?
Radiopharmaceuticals
3
2018
180
0.100
Why?
Neoplasm Invasiveness
1
2012
552
0.090
Why?
CD4 Lymphocyte Count
3
2008
66
0.090
Why?
Transplantation Conditioning
1
2013
373
0.090
Why?
Leukemia, Myeloid, Acute
1
2016
763
0.090
Why?
Renal Dialysis
1
2013
355
0.090
Why?
Lymphoma, Non-Hodgkin
1
2012
261
0.090
Why?
Fatal Outcome
1
2011
295
0.090
Why?
Intention to Treat Analysis
3
2019
72
0.090
Why?
Cyclophosphamide
3
2018
299
0.090
Why?
Models, Biological
1
2016
1752
0.090
Why?
Pregnancy Rate
1
2009
20
0.090
Why?
Neovascularization, Pathologic
1
2011
356
0.090
Why?
Immunohistochemistry
3
2021
1759
0.080
Why?
DNA-Binding Proteins
1
2014
1214
0.080
Why?
Protease Inhibitors
1
2007
72
0.070
Why?
DNA, Mitochondrial
1
2008
183
0.070
Why?
Head and Neck Neoplasms
1
2014
1052
0.070
Why?
Mitochondrial Proteins
1
2008
124
0.070
Why?
Leukocytes, Mononuclear
1
2008
196
0.070
Why?
Consensus
2
2018
336
0.070
Why?
Communication
2
2020
440
0.070
Why?
Neoplasm Grading
2
2020
357
0.070
Why?
Etoposide
2
2018
196
0.060
Why?
Doxorubicin
2
2018
295
0.060
Why?
Carboplatin
2
2018
286
0.060
Why?
Viral Load
2
2019
150
0.060
Why?
Surveys and Questionnaires
2
2023
2502
0.060
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
1075
0.060
Why?
Longitudinal Studies
2
2023
1019
0.060
Why?
Goals
1
2023
67
0.060
Why?
Treatment Failure
2
2014
286
0.060
Why?
Capsules
2
2013
38
0.060
Why?
Morbidity
1
2022
148
0.050
Why?
Vincristine
1
2021
111
0.050
Why?
RNA, Small Interfering
2
2014
547
0.050
Why?
Diploidy
1
2020
30
0.050
Why?
Up-Regulation
2
2014
717
0.050
Why?
Lung Neoplasms
1
2012
2262
0.050
Why?
Therapies, Investigational
1
2019
17
0.040
Why?
Alabama
1
2019
13
0.040
Why?
Antiviral Agents
1
2003
512
0.040
Why?
Consolidation Chemotherapy
1
2019
22
0.040
Why?
Decision Making
2
2019
643
0.040
Why?
Pilot Projects
2
2013
840
0.040
Why?
Epigenesis, Genetic
2
2014
481
0.040
Why?
Hepatomegaly
1
2018
15
0.040
Why?
Filgrastim
1
2018
56
0.040
Why?
Quality of Life
2
2019
1587
0.040
Why?
Recombinant Proteins
1
2021
1017
0.040
Why?
Azepines
1
2018
20
0.040
Why?
Research Design
1
2022
594
0.040
Why?
Retreatment
1
2018
107
0.040
Why?
Ecosystem
1
2021
316
0.040
Why?
Blotting, Western
2
2011
786
0.040
Why?
Receptors, KIR3DL1
1
2017
1
0.040
Why?
Receptors, KIR2DL1
1
2017
4
0.040
Why?
Polymerase Chain Reaction
2
2011
930
0.040
Why?
Comparative Genomic Hybridization
1
2016
39
0.040
Why?
Thymus Hyperplasia
1
2016
3
0.040
Why?
Pregnancy
3
2009
2901
0.040
Why?
Motivation
1
2019
286
0.040
Why?
Glutamate-Cysteine Ligase
1
2016
7
0.040
Why?
Microsatellite Repeats
1
2016
145
0.040
Why?
Fluorodeoxyglucose F18
1
2017
138
0.030
Why?
Ligands
1
2017
433
0.030
Why?
Glutathione
1
2016
104
0.030
Why?
Emotions
1
2019
341
0.030
Why?
Drug Synergism
1
2016
303
0.030
Why?
Cost of Illness
1
2016
150
0.030
Why?
Norepinephrine Plasma Membrane Transport Proteins
1
2015
5
0.030
Why?
Tomography, X-Ray Computed
2
2018
2585
0.030
Why?
Models, Statistical
1
2018
575
0.030
Why?
Acetylation
1
2015
121
0.030
Why?
RNA, Viral
2
2008
330
0.030
Why?
Chicago
1
2019
1380
0.030
Why?
DNA Repair
1
2016
356
0.030
Why?
Cyclohexylamines
1
2014
7
0.030
Why?
Middle Aged
3
2019
25026
0.030
Why?
Suspensions
1
2013
6
0.030
Why?
Physician-Patient Relations
1
2019
610
0.030
Why?
Response Elements
1
2014
63
0.030
Why?
Hematopoietic Stem Cells
1
2016
292
0.030
Why?
International Agencies
1
2013
34
0.030
Why?
Quality Control
1
2014
117
0.030
Why?
Chi-Square Distribution
1
2014
364
0.030
Why?
Hematologic Diseases
1
2013
79
0.030
Why?
Cytosine
1
2014
127
0.030
Why?
Magnetic Resonance Imaging
2
2018
3361
0.030
Why?
Immunoenzyme Techniques
1
2013
303
0.030
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2014
151
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
276
0.030
Why?
Histones
1
2015
311
0.030
Why?
Nervous System Diseases
1
2013
151
0.030
Why?
Adrenalectomy
1
2012
43
0.030
Why?
Chromosomes, Human, Pair 17
1
2012
110
0.030
Why?
Virus Diseases
1
2013
97
0.030
Why?
Gastrointestinal Diseases
1
2013
146
0.030
Why?
Gene Deletion
1
2013
337
0.030
Why?
Skin
1
2015
554
0.030
Why?
Ploidies
1
2011
40
0.030
Why?
Tretinoin
1
2012
126
0.030
Why?
Thymopentin
1
2011
2
0.030
Why?
Drug Resistance, Multiple
1
2011
20
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1960
0.030
Why?
Translocation, Genetic
1
2012
265
0.030
Why?
Isoenzymes
1
2012
271
0.030
Why?
Research
1
2012
253
0.020
Why?
Antibodies
1
2013
352
0.020
Why?
RNA, Messenger
1
2016
1988
0.020
Why?
Receptors, Interleukin-2
1
2010
66
0.020
Why?
Gene Silencing
1
2011
173
0.020
Why?
Australia
1
2010
99
0.020
Why?
Logistic Models
1
2014
1185
0.020
Why?
Biopsy
1
2014
1163
0.020
Why?
Lymphocyte Count
1
2010
94
0.020
Why?
Chemotherapy, Adjuvant
1
2012
468
0.020
Why?
North America
1
2010
180
0.020
Why?
Age Distribution
1
2010
204
0.020
Why?
Japan
1
2010
307
0.020
Why?
Aged
2
2019
18406
0.020
Why?
Europe
1
2010
309
0.020
Why?
Liver Neoplasms
1
2016
736
0.020
Why?
Administration, Oral
1
2011
683
0.020
Why?
Down-Regulation
1
2011
508
0.020
Why?
Gravidity
1
2009
7
0.020
Why?
Transfection
1
2011
898
0.020
Why?
Sex Education
1
2009
9
0.020
Why?
Infectious Disease Transmission, Vertical
1
2009
44
0.020
Why?
Congenital Abnormalities
1
2009
63
0.020
Why?
Contraceptive Agents, Female
1
2009
31
0.020
Why?
Aged, 80 and over
1
2019
6510
0.020
Why?
Cytochromes c
1
2008
27
0.020
Why?
Drug Therapy, Combination
1
2010
895
0.020
Why?
Birth Weight
1
2008
145
0.020
Why?
Body Height
1
2008
99
0.020
Why?
Mice, Transgenic
1
2011
1557
0.020
Why?
Infant, Low Birth Weight
1
2007
58
0.020
Why?
Phenotype
1
2014
2389
0.020
Why?
Lactic Acid
1
2007
90
0.020
Why?
Models, Genetic
1
2012
929
0.020
Why?
Diagnostic Imaging
1
2011
468
0.020
Why?
Genetic Variation
1
2014
1351
0.020
Why?
Triglycerides
1
2007
232
0.020
Why?
Cholesterol, HDL
1
2007
165
0.020
Why?
Pregnancy Outcome
1
2007
247
0.020
Why?
Health Knowledge, Attitudes, Practice
1
2009
508
0.020
Why?
Disease Models, Animal
1
2011
2243
0.020
Why?
Hepatitis A Vaccines
1
2003
3
0.020
Why?
Hepatitis A Antibodies
1
2003
3
0.020
Why?
Mumps virus
1
2003
3
0.020
Why?
Tetanus Toxoid
1
2003
10
0.020
Why?
Mycobacterium avium-intracellulare Infection
1
2003
5
0.010
Why?
Azithromycin
1
2003
13
0.010
Why?
Antibodies, Bacterial
1
2003
99
0.010
Why?
Acquired Immunodeficiency Syndrome
1
2003
78
0.010
Why?
Signal Transduction
1
2012
3267
0.010
Why?
Anti-Bacterial Agents
1
2003
747
0.010
Why?
Cohn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (412)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_